Company: NCEL
Filing Date: 2025-10-24
Form Type: POS AM
Source: 0001213900-25-102149
Chunk: 65

Company: NewcelX Ltd.
Filing Date: 2025-10-24
Form: POS AM
Chunk 65
---
 maintains an Internet website that contains reports and other information regarding issuers that file electronically with the SEC. Our filings with the SEC are also available to the public through the SEC’s website atwww.sec.gov.

We are subject to the information
reporting requirements of the Exchange Act that are applicable to foreign private issuers, and under those requirements are filing reports
with the SEC. Those other reports or other information may be inspected without charge at the locations described above. As a foreign
private issuer, we are exempt from the rules under the Exchange Act related to the furnishing and content of proxy statements, and our
officers, directors and principal shareholders are exempt from the reporting and short-swing profit recovery provisions contained in Section 16
of the Exchange Act. In addition, we are not required under the Exchange Act to file annual, quarterly and current reports and financial
statements with the SEC as frequently or as promptly as U.S. companies whose securities are registered under the Exchange Act. However,
we are required to file with the SEC, within 120 days after the end of each fiscal year, or such applicable time as required by the
SEC, an annual report on Form 20-F containing financial statements audited by an independent registered public accounting firm, and
will submit to the SEC, on Form 6-K, unaudited interim financial information.

We maintain a corporate website
at https://nlspharma.com. Information contained on, or that can be accessed through, our website does not constitute a part of this prospectus.
We have included our website address in this prospectus solely as an inactive textual reference. We will post on our website any materials
required to be so posted on such website under applicable corporate or securities laws and regulations, including, posting any XBRL interactive
financial data required to be filed with the SEC and any notices of general meetings of our shareholders.

<div align='center'>39

PROSPECTUS

, 2025

PART II

INFORMATION NOT REQUIRED IN PROSPECTUS</div>

Item 6. Indemnification of Directors, Officers and Employees

Indemnification

Under Swiss law, a corporation
may indemnify its directors or officers against losses and expenses (except for such losses and expenses arising from willful misconduct
or negligence, although legal scholars advocate that at least gross negligence be required; however, some scholars also advocate that
with any breach of duty, indemnification by the Company is not permissible), including attorney’s fees, judgments, fines